The disease is a consequence of pathogenic variants in the glucocerebrosidase gene (GBA1) (MIM*606403) and can be classified into three clinical subtypes based on the age of onset, clinical signs, rate of progression, or absence of neurologic disease [4]. Here, GBA1 is linked to nervous system disorder.